
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HeLa (human cervical epithelial adenocarcinoma cell line) cells labeling BCL9 with M04057 at 1/25 dilution, followed by Dylight® 488-conjugated goat anti-rabbit IgG secondary antibody at 1/200 dilution (green). Immunofluorescence image showing nucleus staining on HeLa cell line. Cytoplasmic actin is detected with Dylight® 554 Phalloidin at 1/100 dilution (red).
Anti-BCL9 Antibody (N-Term)
M04057
ApplicationsImmunoFluorescence, Western Blot
Product group Antibodies
TargetBCL9
Overview
- SupplierBoster Bio
- Product NameAnti-BCL9 Antibody (N-Term)
- Delivery Days Customer9
- ApplicationsImmunoFluorescence, Western Blot
- CertificationResearch Use Only
- ClonalityPolyclonal
- Gene ID607
- Target nameBCL9
- Target descriptionBCL9 transcription coactivator
- Target synonymsB cell CLL/lymphoma 9; B-cell CLL/lymphoma 9 protein; B-cell lymphoma 9 protein; bcl-9; LGS; protein legless homolog
- HostRabbit
- IsotypeIgG
- Protein IDO00512
- Protein NameB-cell CLL/lymphoma 9 protein
- Scientific DescriptionBoster Bio Anti-BCL9 Antibody (N-Term) (Catalog # M04057). Tested in WB, IF application(s). This antibody reacts with Human, Mouse.
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203